Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score 3.24
- Piotroski Score 7.00
- Grade Hold
- Symbol (TFX)
- Company Teleflex Incorporated
- Price $190.65
- Changes Percentage (1.72%)
- Change $3.22
- Day Low $187.52
- Day High $191.23
- Year High $257.85
Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. It provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site. The company also offers interventional products, which consists of various coronary catheters, structural heart therapies, and peripheral intervention and cardiac assist products that are used by interventional cardiologists and radiologists, and vascular surgeons; and Arrow branded catheters, Guideline and Trapliner catheters, the Manta Vascular Closure, and Arrow Oncontrol devices. It provides anesthesia products, such as airway and pain management products to support hospital, emergency medicine, and military channels; and surgical products, including metal and polymer ligation clips, and fascial closure surgical systems that are used in laparoscopic surgical procedures, percutaneous surgical systems, and other surgical instruments. The company also offers interventional urology products comprising the UroLift System, an invasive technology for treating lower urinary tract symptoms due to benign prostatic hyperplasia; and respiratory products, including oxygen and aerosol therapies, spirometry, and ventilation management products for use in various care settings. It provides urology products, such as catheters, urine collectors, and catheterization accessories and products for operative endourology; and bladder management services. The company serves hospitals and healthcare providers, medical device manufacturers, and home care markets. The company was incorporated in 1943 and is headquartered in Wayne, Pennsylvania.
- Last Earnings 10/31/2024
- Ex-Dividend for 5/16 Dividend 11/15/2024
- Dividend Payable 12/16/2024
- Today N/A
- Next Earnings (Estimated) 02/20/2025
- Fiscal Year End N/A
- Average Stock Price Target $275.00
- High Stock Price Target $415.00
- Low Stock Price Target $240.00
- Potential Upside/Downside N/A
- Consensus Rating Neutral
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) $6.25
- Trailing P/E Ratio 34.01
- Forward P/E Ratio 34.01
- P/E Growth 34.01
- Net Income $356.33 M
Income Statement
Quarterly
Annual
Latest News of TFX
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
Insider Sale: Director Stuart Randle Sells Shares of Teleflex Inc (TFX)
Teleflex Inc is a global medical technology provider focused on enhancing lives. Its stock is priced at $238.93 with a market cap of $11.27 billion. The company's fair value is $259.22, indicating it ...
By Yahoo! Finance | 3 months ago -
Decoding Teleflex Inc (TFX): A Strategic SWOT Insight
Teleflex Inc, a leading medical device manufacturer, reports revenue growth but declining net income. Strategic acquisitions and global reach bolster its market position. Challenges include market sen...
By Yahoo! Finance | 3 months ago -
Should You Sell Teleflex Incorporated (TFX)?
Aristotle Atlantic Partners, LLC's Core Equity Strategy outperformed the S&P 500 Index in Q2 2024, with Teleflex Incorporated as a highlighted stock pick. The company's revenue increased, but concerns...
By Yahoo! Finance | 3 months ago
